ArticleInternal medicine (Tokyo, Japan)2025

Addressing Cardiotoxicity Risks in Long-term Use of Human Epidermal Growth Factor Receptor 2 Inhibitors.

Kazuko TajiriPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.